2016
DOI: 10.1016/j.biomaterials.2016.08.048
|View full text |Cite
|
Sign up to set email alerts
|

Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(30 citation statements)
references
References 31 publications
0
29
1
Order By: Relevance
“…The present results match those reported by Xiao et al . 52 and exceed those reported by Khademi et al . 53
Figure 1 The UV spectrum ( a ) zeta potential ( b ) particle size and particle size distribution ( c ) transmission electron microscopy ( d ) and X-ray diffraction ( e ) of formed gold nanoparticles (AuNPs).
…”
Section: Resultscontrasting
confidence: 54%
“…The present results match those reported by Xiao et al . 52 and exceed those reported by Khademi et al . 53
Figure 1 The UV spectrum ( a ) zeta potential ( b ) particle size and particle size distribution ( c ) transmission electron microscopy ( d ) and X-ray diffraction ( e ) of formed gold nanoparticles (AuNPs).
…”
Section: Resultscontrasting
confidence: 54%
“…Nowadays, lots of literatures report the possibility of multimodality molecular imaging using nanoprobes, which supports the notion that clinical translation of this technology will be feasible in the near future [7,9,10]. Hence, the purpose of this review is to provide readers with a current update of multimodality molecular imaging of cardiovascular disease based on nanoprobes, which focus on six important aspects of cardiovascular diseases, including atherosclerosis, thrombosis, myocardial infarction and postinfarction remodeling, angiogenesis, apoptosis and cardiac stem cell-based therapy.…”
Section: Introductionmentioning
confidence: 84%
“…However, these methods could not accurately in vivo assess plaque characterization at the molecular level and evaluate the severity of atherosclerotic plaques. To meet this need, different molecular probes based on various nanomaterials have been developed and applied as novel approaches for imaging related biomarkers of atherosclerosis [10,15,16].…”
Section: Imaging Of Atherosclerosis and Vulnerable Plaquementioning
confidence: 99%
“…Commonly used as good contrasting agents are gadoliniumbased substances; with adverse characteristics including cytotoxicity and the persistent accumulation of gadolinium. Iron oxide magnetic nanoparticles have better results as magnetic resonance imaging contrasting agents when compared with gadolinium and manganese oxide nanoparticles (Li et al, 2016). Gadolinium-based formulations are still dominating contrasting agents; however, after a careful survey of literature and recent clinical trials evidences, the future of iron oxide magnetic nanoparticles is highly promissory for diagnostic imaging guided therapy with the suitable incorporation of specific ligands to well-defined pathologies.…”
Section: Atherosclerosismentioning
confidence: 99%